Value and Implementation of Patient and Public Involvement and Engagement in Health Technology Assessment for Japan: implications from systematic searches

被引:0
作者
Kaneyasu, Takako [1 ]
机构
[1] Ritsumeikan Univ, Coll Life Sci, Dept Biomed Sci, Kusatsu, Shiga, Japan
关键词
patient and public involvement; patient engagement; public engagement; health technology assessment;
D O I
10.1017/S026646232500008X
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives This study comprehensively reviewed reports on patient and public involvement and engagement (PPIE) in health technology assessment (HTA) overseas and identified the status and possible future measures, of PPIE in Japanese HTA.Methods The series of reviews targeted systematic reviews (SR#1), references in SR#1 (SR#2), and new articles after SR#1 (SR#3). The MEDLINE and Embase databases were searched through August 2024 using the terms "patient involvement/engagement," "patient participation," "community participation," "public involvement/engagement," and "health technology assessment." The implementation details were extracted from information published on the websites of the HTA agencies.Results Three review articles in SR#1, 12 references in SR#2, and 10 articles in SR#3 were selected. The opportunities for countries, including Japan, to participate in discussions on the HTA process did not differ significantly; however, information on PPIE in Japan was scarce and did not indicate their purpose and value.Conclusions Collected articles indicated that the value of PPIE in HTA includes relevance, equity, fairness, legitimacy, and capacity building. The participation of patient and public representatives in Japanese discussions since 2005 appeared to be very limited to consider PPIE in HTA. In countries that implement PPIE in HTA, the value of PPIE is explicit: the process guidelines are specific and provide an appropriate environment for input that includes education, training, and feedback. Future reforms of the Japanese system will require discussions on PPIE purpose and value, implementation, and creating an environment in which a diverse range of patients and the public can easily express their views.
引用
收藏
页数:11
相关论文
共 66 条
  • [1] PUBLIC AND PATIENT INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT: A FRAMEWORK FORACTION
    Abelson, Julia
    Wagner, Frank
    DeJean, Deirdre
    Boesveld, Sarah
    Gauvin, Francois-Pierre
    Bean, Sally
    Axler, Renata
    Petersen, Stephen
    Baidoobonso, Shamara
    Pron, Gaylene
    Giacomini, Mita
    Lavis, John
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2016, 32 (04) : 256 - 264
  • [2] The representation of public values in health technology assessment to inform funding decisions: the case of Australia's national funding bodies
    Afzali, Hossein Haji Ali
    Street, Jackie
    Merlin, Tracy
    Karnon, Jonathan
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2021, 37 (01)
  • [3] AMED Research Committee on Survey of Trends in Patient and the Public Involvement in Clinical Research, 2019, Patient and Public Involvement (PPI) Guidebook
  • [4] [Anonymous], Patient and public involvement policy
  • [5] [Anonymous], HTA Core Model
  • [6] Creating a patient and community advisory committee at the Canadian Agency for Drugs and Technologies in Health
    Berglas, Sarah
    Vautour, Nadine
    Bell, Daryl
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2021, 37 (01)
  • [7] Patients’ perspectives can be integrated in health technology assessments: An exploratory analysis of CADTH common drug review
    Berglas S.
    Jutai L.
    Mackean G.
    Weeks L.
    [J]. Research Involvement and Engagement, 2 (1)
  • [8] Canada's Drug Agency, 2020, Reimbursement Reviews Process in Brief
  • [9] Canada's Drug Agency, 2019, Values for Patient Involvement in Action at CADTH
  • [10] Canada's Drug and Health Technology Agency, 2019, Framework for Patient Engagement in Health Technology Assessment